THER ADV HEMATOL - Therapeutic Advances in Hematology
Publications
- 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Marchetti, M., Salmanton-García, J., El-Ashwah, S., Verga, L., Itri, F., Ráčil, Z., Dávila-Valls, J., Martín-Pérez, S., Van Doesum, J., Passamonti, F., Abu-Zeinah, G., Farina, F., López-García, A., Dragonetti, G., Cattaneo, C., Gomes Da Silva, M., Bilgin, Y. M., Žák, P., Petzer, V., Glenthøj, A., Espigado, I., Buquicchio, C., Bonuomo, V., Prezioso, L., Meers, S., Duarte, R., Bergantim, R., Jaksic, O., Čolović, N., Blennow, O., Cernan, M., Schönlein, M., Samarkos, M., Mitra, M. E., Magliano, G., Maertens, J., Ledoux, M-P., Jiménez, M., Demirkan, F., Collins, G. P., Cabirta, A., Gräfe, S. K., Nordlander, A., Wolf, D., Arellano, E., Cordoba, R., Hanakova, M., Zambrotta, G. P. M., Nunes Rodrigues, R., Limberti, G., Marchesi, F., Cornely, O. A. & Pagano, L., 2023, In: THER ADV HEMATOL. 14, 20406207231154706.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review